加拿大阿尔伯塔省流感疫苗接种与卒中风险的关联:一项基于人群的研究
该研究利用加拿大阿尔伯塔省全民医保行政数据,纳入2009年9月30日至2018年12月31日期间4 141 209名成人,比较近期(<182天)流感疫苗接种者与未接种者的卒中风险。经调整人口学和合并症后,近期接种显著降低卒中风险(HR 0.775,95%CI 0.757-0.793),且该关联见于所有卒中亚型,除无高血压者外各年龄和风险人群均一致。
要点
- 近期(<182天)流感疫苗接种与卒中风险降低相关(HR 0.775,95%CI 0.757-0.793)。
- 该关联持续见于所有卒中亚型,包括缺血性卒中、脑出血、蛛网膜下腔出血和短暂性脑缺血发作。
- 除无高血压个体外,各年龄和风险特征人群总体均显示接种与卒中风险降低相关。
核心结论
- 近期接种流感疫苗者较未接种者卒中风险降低,该关联扩展至整个成人 population,不限于基线卒中高风险个体。
- 作者指出需在不同环境中进一步研究,以评估流感疫苗接种能否作为预防卒中的公共卫生策略。
研究设计与样本
- 基于人群的研究,数据来自阿尔伯塔省医疗保险计划行政数据,覆盖加拿大阿尔伯塔省所有居民。
- 纳入2009年9月30日或居民记录为18岁当年5月15日起的数据,随访截止于死亡、记录迁出或2018年12月31日中最先发生者。
- 研究样本为2009年9月30日至2018年12月31日期间注册的4 141 209名成人,观察人时为29 687 899人年。
- 采用Andersen-Gill Cox模型分析近期(<182天)流感疫苗接种者相比无近期接种者的任何卒中事件风险,并调整年龄、性别、抗凝药使用、心房颤动、慢性阻塞性肺疾病、糖尿病、高血压、收入五分位和城乡居住地。
主要发现
- 研究期间1 769 565人(42.73%)至少接种一次疫苗,共记录38 126例卒中事件。
- 调整人口学和合并症后,近期流感疫苗接种显著降低卒中风险(HR 0.775,95%CI 0.757-0.793)。
- 该关联持续见于所有卒中亚型。
- 除居住地外,每个 examined 协变量均存在效应修饰;但总体而言,除无高血压个体外,各年龄和风险特征人群接种均与卒中风险降低相关。
关键数值与推荐
- 近期流感疫苗接种定义为接种后<182天。
- 卒中结局包括急性缺血性卒中、脑出血、蛛网膜下腔出血和短暂性脑缺血发作。
- 主要效应量:近期接种者相比无近期接种者任何卒中事件的HR为0.775(95%CI 0.757-0.793)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 作者指出需在不同环境中进一步研究,以评估流感疫苗接种能否作为预防卒中的公共卫生策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Respiratory infection can be an immediate precursor to stroke and myocardial infarction. Influenza vaccination is associated with reduced risk of myocardial infarction and hospitalisation for cardiac disease, and influenza vaccination is strongly recommended for patients with heart disease. Evidence on whether the same protective association exists for stroke, and whether this potential effect is consistent across age and risk groups, is conflicting. We aimed to assess the risk of stroke after influenza vaccination in adults. METHODS: We obtained administrative data from the Alberta Health Care Insurance Plan (which covers all residents of Alberta, Canada) beginning on Sept 30, 2009, or May 15 of the year in which residents were recorded as being 18 years of age. Individuals were censored at the earliest of three events: death, recorded outmigration, or Dec 31, 2018. The outcome of interest was any stroke event, comprising acute ischaemic stroke, intracerebral haemorrhage, subarachnoid haemorrhage, and transient ischaemic attack. We used Andersen-Gill Cox models to analyse the hazard of any stroke event for individuals with recent (<182 days) influenza vaccination compared with those without recent influenza vaccination, with adjustment for age, sex, anticoagulant use, atrial fibrillation, chronic obstructive pulmonary disease, diabetes, hypertension, income quintile, and rural or urban home location. Two-way interaction terms between each individual covariate and vaccination status were used to assess for effect modification by risk factor. The association between vaccination and risk of each type of stroke was also modelled, adjusting for baseline covariates. FINDINGS: The study sample consisted of 4 141 209 adults (29 687 899 person-years of observation time) registered under the provincial health-care system between Sept 30, 2009, and Dec 31, 2018. 1 769 565 (42·73%) individuals received at least one vaccination during the study period, and 38 126 stroke events were recorded. Adjusted for demographics and comorbidities, recent influenza vaccination significantly reduced the hazard of stroke (hazard ratio 0·775 [95% CI 0·757-0·793]). This association persisted across all stroke types. We found effect modification by each covariate examined except for home location; however, vaccination was associated with a reduced risk of stroke overall across all ages and risk profiles with the exception of individuals without hypertension. INTERPRETATION: The risk of stroke is reduced among people who have recently been vaccinated against influenza compared with those who have not. This association extended to the entire adult population and was not limited to individuals with a baseline high risk of stroke. Further studies in a variety of settings are needed to evaluate whether influenza vaccination could be used as a public health strategy to prevent stroke. FUNDING: None.
引用
- Holodinsky JK, Zerna C, Malo S, et al. Association between influenza vaccination and risk of stroke in Alberta, Canada: a population-based study. Lancet Public Health. 2022. PMID: 36334607. doi:10.1016/S2468-2667(22)00222-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。